Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 7
2018 7
2019 8
2020 4
2021 3
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Emergency versus elective ureteroscopy for the management of ureteral stones.
Gadzhiev NK, Akopyan GN, Tursunova FI, Afyouni AS, Korolev DO, Tsarichenko DG, Rapoport LM, Okhunov Z, Bhaskar S, Malkhasyan VA. Gadzhiev NK, et al. Among authors: rapoport lm. Urologia. 2022 Feb;89(1):79-84. doi: 10.1177/0391560320987163. Epub 2021 Jan 9. Urologia. 2022. PMID: 33427095
Intraoperative prophylactic intravesical chemotherapy to reduce bladder recurrence following radical nephroureterectomy.
Freifeld Y, Ghandour R, Singla N, Woldu S, Bagrodia A, Lotan Y, Rapoport LM, Gazimiev M, Delafuente K, Kulangara R, Robyak H, Petros FG, Raman JD, Matin SF, Margulis V. Freifeld Y, et al. Among authors: rapoport lm. Urol Oncol. 2020 Sep;38(9):737.e11-737.e16. doi: 10.1016/j.urolonc.2020.05.002. Epub 2020 Jul 5. Urol Oncol. 2020. PMID: 32641241
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy.
Yeh HC, Margulis V, Singla N, Hernandez E, Panwar V, Woldu SL, Karam JA, Wood CG, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Roscigno M, Bolenz C, Bensalah K, Li CC, Ke HL, Li WM, Lee HY, Rapoport LM, Lotan Y, Kapur P, Shariat SF, Hsieh JT, Wu WJ. Yeh HC, et al. Among authors: rapoport lm. Urol Oncol. 2020 May;38(5):496-505. doi: 10.1016/j.urolonc.2019.11.010. Epub 2019 Dec 18. Urol Oncol. 2020. PMID: 31862213
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer.
Kimura S, D'Andrea D, Iwata T, Foerster B, Janisch F, Parizi MK, Moschini M, Briganti A, Babjuk M, Chlosta P, Karakiewicz PI, Enikeev D, Rapoport LM, Seebacher V, Egawa S, Abufaraj M, Shariat SF. Kimura S, et al. Among authors: rapoport lm. World J Urol. 2020 Oct;38(10):2501-2511. doi: 10.1007/s00345-019-03038-5. Epub 2019 Dec 4. World J Urol. 2020. PMID: 31797075
Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancer.
Iwata T, Kimura S, Abufaraj M, Janisch F, Parizi MK, Haitel A, Rink M, Rouprêt M, Fajkovic H, Seebacher V, Nyirady P, Karakiewicz PI, Enikeev D, Rapoport LM, Nasu Y, Shariat SF. Iwata T, et al. Among authors: rapoport lm. Urol Oncol. 2019 Oct;37(10):774-783. doi: 10.1016/j.urolonc.2019.05.019. Epub 2019 Jun 27. Urol Oncol. 2019. PMID: 31255543
26 results